Innovative strategies for the elimination of viral hepatitis at a national level: A country case series

Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost‐effective. In 2016, all 194 member states...

Full description

Saved in:
Bibliographic Details
Published in:Liver international 2019-10, Vol.39 (10), p.1818-1836
Main Authors: Schröeder, Sophia E., Pedrana, Alisa, Scott, Nick, Wilson, David, Kuschel, Christian, Aufegger, Lisa, Atun, Rifat, Baptista‐Leite, Ricardo, Butsashvili, Maia, El‐Sayed, Manal, Getahun, Aneley, Hamid, Saeed, Hammad, Radi, ‘t Hoen, Ellen, Hutchinson, Sharon J., Lazarus, Jeffrey V., Lesi, Olufunmilayo, Li, Wangsheng, Binti Mohamed, Rosmawati, Olafsson, Sigurdur, Peck, Raquel, Sohn, Annette H., Sonderup, Mark, Spearman, Catherine W., Swan, Tracy, Thursz, Mark, Walker, Tim, Hellard, Margaret, Howell, Jessica
Format: Article
Language:English
Subjects:
Case studies
Correctional personnel
developing countries
disease elimination
Epidemics
Feasibility
Global Burden of Disease
Health Resources - statistics & numerical data
Health risks
Health Services Accessibility - legislation & jurisprudence
Health Services Accessibility - statistics & numerical data
Hepatitis
hepatitis B
Hepatitis B - prevention & control
Hepatitis B - therapy
hepatitis C
Hepatitis C - prevention & control
Hepatitis C - therapy
Humans
International policy
Investment
investment case
Models, Organizational
Morbidity
Organizational Case Studies
Public health
Public Health - legislation & jurisprudence
Public Health - statistics & numerical data
Review
Reviews
Sustainable Development
World Health Organization
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost‐effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence‐gathering and planning; (b) implementation; and (c) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints.
ISSN:1478-3223
1478-3231
1478-3231
DOI:10.1111/liv.14222